Monday, 16 December 2019

Drug Discovery News

  • Aquavit, Green Cross sign MoU

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 09 Aug, 2012

    Singapore: Green Cross, a leading biotechnology company in South Korea, has signed a memorandum of understanding (MOU) with US-based Aquavit Pharmaceuticals for strategic collaboration sur...Read more

  • Chugai gets Japanese nod cancer drug Kadcyla

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 23 Sep, 2013

    Singapore: The Japanese Ministry of Health, Labour and Welfare has approved Oncology specializing pharmaceutical firm Chugai Pharmaceutical's anti-cancer agent Kadcyla, for HER2-positive in...Read more

  • Nexavar seeks marketing authorization in Japan

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 01 Oct, 2013

    Singapore: Bayer HealthCare has submitted an additional application for marketing authorization to the Ministry of Health, Labour and Welfare (MHLW) in Japan for Nexavar (Sorafenib) tablets...Read more

  • Starpharma to receive $6 mn for overseas R&D

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 23 Nov, 2012

    Singapore: Australia-based Starpharma is eligible to receive approximately $6 million cash in R&D tax incentives for overseas research activities related to VivaGel. Starpharma has made...Read more

  • Thermo Fisher Scientific celebrates 20th year in Singapore

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 30 Aug, 2016

    Singapore: Thermo Fisher Scientific has completed 20th year of its operation in Singapore. The company celebrated the milestone on August 30, 2016 at Block 33, Marsiling Industrial Estate ...Read more

  • FDA to review Vanda blindness drug Tasimelteon

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 31 Jul, 2013

    Singapore: The US FDA has granted priority review classification to Vanda's New Drug Application (NDA) for tasimelteon, a circadian regulator for the treatment of Non-24-Hour Disorder (Non-...Read more

  • Novartis' Jakavi improves myelofibrosis

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 11 Dec, 2012

    Singapore: Phase III studies by Novartis has demonstrated that Jakavi (INC424, ruxolitinib) treatment resulted in sustained reductions in spleen size, a hallmark of myelofibrosis, while als...Read more

  • Quest signs $2mn development deal with Korean firm

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Jul, 2013

    Singapore: Quest PharmaTech, a pharmaceutical company developing and commercializing products for the treatment of cancer, entered into a long term strategic relationship with AD Biotech, a...Read more

  • EU approves Novartis' Bexsero for meningitis

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 23 Jan, 2013

    Singapore: European Commission has approved Novartis' Bexsero (Meningococcal Group B Vaccine [rDNA, component, adsorbed]) for use in individuals from two months of age and older. "This men...Read more

  • Material science firm Crystal to open lab in China

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 02 Jan, 2013

    Singapore: Crystal Pharmatech is going to open its laboratories in China in order to provide customized, materials science development service packages in drug R&D. Crystal has adopte...Read more

  • ShangPharma celebrates 10 years with Eli Lilly

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 05 Jun, 2012

    Singapore: ShangPharma, a China-based pharmaceutical and biotechnology research and development outsourcing company, celebrated the 10th anniversary of its partnership with Eli Lilly. "I a...Read more

  • Google, Facebook, Apple invite nominations for 2014 'Breakthrough Prize'

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 04 Sep, 2013

    Singapore: Breakthrough Prize in Life Sciences Foundation has opened its process of online nomination for the 2014 prizes. The nominations could be made using the website www.breakthroughpr...Read more

  • Bionomics cancer trial shows +ve results

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 03 Feb, 2014

    Singapore: Australian drug discovery firm, Bionomics, has received positive results in the phase I clinical trial of its cancer drug candidate BNC105 in women with ovarian cancer. After com...Read more

  • New drug slows cancer significantly

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Dec, 2012

    Singapore: A study by University of Michigan Comprehensive Cancer Center researchers demonstrated that a new drug has dramatic and rapid effects on prostate cancer, which had already spread...Read more

  • Shionogi launches London headquarter

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 06 Jul, 2012

    Singapore: Japan-based pharmaceutical company Shionogi has launched its new European Headquarters in London, UK, to be called Shionogi Limited. The new headquarters will form a new era for ...Read more

  • Tetraphase antibiotic gets FDA QIDP designation

    Drug Discovery |  Regulatory | By BioSpectrum Bureau  | 0 Comment | 22 Jul, 2013

    Singapore: US-based Tetraphase Pharmaceuticals has received approval from US FDA for its lead antibiotic product candidate, eravacycline, as a Qualified Infectious Disease Product (QIDP).QI...Read more

  • Zhejiang Medicine, Ambrx to develop antibody drug conjugate for breast cancer

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2014

    Singapore: Clinical stage biopharmaceutical company, Ambrx and China's Zhejiang Medicine (ZMC) have formed a collaboration to develop and commercialize ARX788, Ambrx's most advanced interna...Read more

  • Novartis to ship 30 mn flu vaccine to US

    Drug Discovery |  News | By BioSpectrum Bureau  | 0 Comment | 24 Apr, 2013

    Singapore: Novartis plans to ship around 30 million doses of its influenza vaccines including Fluvirin and Flucelvax to customers in the US market for the 2013-2014 season. In clinical stud...Read more



Podcast

 

Survey Box

Is APAC region emerging as a leader in assistive technologies?

× Please select an option to participate in the poll.
Processing...   View poll results   More polls

× You have successfully cast your vote.
{{ optionDetail.option }}{{ optionDetail.percentage }}%
{{ optionDetail.percentage }}% Complete
More polls